4 results
Now showing1 - 4 of 4
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Access status: with files , Characterization of the Synomag®-D-PEG-OMe nanoparticles for the encapsulation in human and murine red blood cells(Infinite Science Publishing, 2022-03-21); ; ; ; It was shown that the encapsulation of SPIO-based contrast agents in the red blood cells (RBCs) increases the circulation time in blood of these nanomaterials. Not all iron oxide particles are eligible for the entrapment into RBCs, depending on several factors and synthesis protocol. We have recently identified some type of nanoparticles that can be loaded with our method into RBCs to produce biocompatible SPIO-RBCs carriers that could be used as new intravascular tracers for biomedical applications, such as Magnetic Particle Imaging (MPI). Here, we report the first in vitro results obtained by using the Synomag®-D-PEG-OMe nanoparticles with both human and murine RBCs. MPS analysis showed that human Synomag®-D-PEG-OMe-loaded RBCs produced a signal that is weaker respect to the remarkable signal obtained with ferucarbotran loaded-RBCs prepared at the same condition, but it is to be noted that the encapsulation efficiency of Synomag®-D-PEG-OMe into cells is lower compared to ferucarbotran nanoparticles.Publicationtype: Journal ArticleScopus© Citations 1 62 191 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Access status: with files , Encapsulation in human and murine erythrocytes of the Synomag®-D-PEG-OMe tracer for MPI application(Infinite Science Publishing, 2022); ; ; ; Recently, the potential of red blood cells (RBCs) loaded with superparamagnetic iron oxide (SPIO)-based nanoparti-cles as new blood-pool tracer material for the Magnetic Particle Imaging (MPI) has been investigated. It was shown that the encapsulation of SPIO-based contrast agents in the RBCs increase the circulation time in blood of these nanomaterials. However, not all iron oxide nanoparticles are eligible to the encapsulation into RBCs, depending on several factors such as dispersant agent nature, nanoparticle size and synthesis protocol. Therefore, we have recently started a program to identify those nanoparticles that can be potentially loaded with our method into RBCs. The goal is to produce biocompatible SPIO-RBCs carriers that can be used as new intravascular magnetic susceptible agents in biomedical applications, such as MRI and MPI. Here, we report the in vitro results obtained by using the Synomag®-D-PEG-OMe nanoparticle suspension (micromod Partikeltechnologie GmbH) with both human and murine red blood cells. MPS analysis showed that human Synomag®-D-PEG-OMe-loaded RBCs produced a signal that is weaker respect to the remarkable signal of ferucarbotran loaded-RBCs prepared at the same condition, but it is to be noted that the encapsulation efficiency of Synomag®-D-PEG-OMe into cells is lower compared to ferucarbotran nanoparticles.Publicationtype: Journal ArticleScopus© Citations 1 40 38 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Access status: with files , Encapsulation of new MPI tracer nanoparticles in the human red blood cells(Infinite Science Publishing, 2020-09-02); ; ; ; Although Magnetic Particle Imaging (MPI) is not yet in clinical use, it is highly promising for several medical ap-plications, and especially for applications in diagnostic vascular in vivo imaging and imaging-guided vascular interventions. Furthermore, in the last years, different superparamagnetic iron oxide (SPIO) based contrast agents have been developed and approved for niche clinical applications in Magnetic Resonance Imaging (MRI) as alterna-tive to Gadolinium-based contrast agents (GBCAs) due to the risk for patients suffering from kidney dysfunction or nephrogenic systemic fibrosis (NSF). Recently, the potential of RBCs loaded with different SPIO nanoparticles as blood-pool tracer agents with longer blood retention time for MRI and MPI has been investigated. Here, we report the first in vitro results with the highly efficient dextran-based MPI tracer particles perimag® and synomag®-D to study their eligibility to be encapsulated into human RBCs and the potential of these new SPIO-RBC constructs as tracer material for MPI.Publicationtype: Journal ArticleScopus© Citations 3 70 113 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Access status: with files , Quasi-simultaneous magnetic particle imaging and navigation of nanomag/synomag-D particles in bifurcation flow experiments(Infinite Science Publishing, 2020-09-02); ; ; ; Magnetic Particle Imaging (MPI) is used to visualize the distribution of superparamagnetic nanoparticles within 3D volumes with high sensitivity in real time. Recently, MPI is utilized to navigate micron-sized particles and micron-sized swimmers, since the magnetic field topology of the MPI scanner is well suited to apply magnetic forces. In this work, we analyze the magnetic mobility and imaging performance of nanomag/synomag-D for Magnetic Particle Imaging/Navigation (MPIN). With MPIN the focus fields are constantly switching between imaging and magnetic force mode, thus enabling quasi-simultaneous navigation and imaging of particles. In flow bifurcation experiment with a 100 % stenosis on one branch, we determine the limiting flow velocity of 1.36 mL/s, which allows all particles to flow only through one branch towards the stenosis. During this experiment, we image the accumulation of the particles within the stenosis. In combination with therapeutic substances, this approach has high potential for targeted drug delivery.Publicationtype: Journal ArticleScopus© Citations 4 109 82